The use of imiquimod to minimize the surgical defect when excising invasive malignant melanoma surrounded by extensive melanoma in situ, lentiginous type.
Missall
Tricia A
TA
Department of Dermatology, Saint Louis University Cancer Center, Saint Louis University School of Medicine, Missouri, 63104, USA.
Fosko
Scott W
SW
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000627:therapeutic use*; D002610:Cheek; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D012535:Scalp; D012878:Skin Neoplasms / Q000473:pathology / Q000601:surgery*; D014945:Wound Healing / Q000187:drug effects*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod